https://www.selleckchem.com/products/ABT-888.html
Immunostaining showed that resveratrol inhibited CD31 Emcn angiogenesis and high expression of VEGFA and Angiopoietin-1. Resveratrol inhibits osteoclast differentiation and reduces active bone resorption by regulating the OPG/RANKL/RANK pathway, and inhibits the abnormal proliferation of CD31 Emcn blood vessels by downregulating the expression of VEGFA and Angiopoiein-1, thereby eliminating the pathologic coupling mechanism of osteogenesis and vascularization, and delaying the progression of osteoarthritis. Resveratrol inhibits osteocla
Curtir
Comentario
Compartilhar
